Ligand Pharmaceuticals Inc. ( LGND ) was a big mover last session, as the company saw its shares rise by over 5% on the day. The move came on solid volume too with far more shares changing hands than in a normal session. This continues the recent uptrend of the company as the stock has now gained roughly 27% since Nov 7.JAZZ PHARMACEUT (JAZZ): Free Stock Analysis ReportLANNETT INC (LCI): Free Stock Analysis ReportLIGAND PHARMA-B (LGND): Free Stock Analysis ReportQUESTCOR PHARMA (QCOR): Free Stock Analysis ReportTo read this article on Zacks.com click here.Zacks Investment Research
This healthcare company has seen a mixed track record when it comes to estimate revision with an upward and downward revision apiece in the past one month. The Zacks Consensus Estimate hasn't been in a trend either. The recent price action is encouraging though, so make sure to keep a close watch on this firm in the near future.
Ligand Pharmaceuticals currently has a Zacks Rank #3 (Hold) while its Earnings ESP is positive.
Some better-ranked stocks in the same industry include Jazz Pharmaceuticals Public Limited Company ( JAZZ ), Lannett Company, Inc. ( LCI ) and Questcor Pharmaceuticals, Inc. ( QCOR ). All these stocks hold a Zacks Rank #1 (Strong Buy).
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report >>